Experimental approach uses AI to eliminate cold storage for mRNA vaccines
· Source: pharma.economictimes.indiatimes.com
In short
Using artificial intelligence, researchers tweaked the lipid nanoparticles that carry mRNA so the vaccines can remain stable at room temperature for up to a year, or at nearly 100 degrees Fahrenheit for two months, according to a study in Nature Biotechnology. Vaccines tolerating higher temperatures could cut storage costs by up to 86%, easing cold-chain infrastructure burdens. The report also covers AI-based detection of heart transplant rejection and research on how chronic tobacco smoke exposure raises lung cancer risk.
Read Original Article — Read the full article on the publisher’s site.
In the issue of week 41, 2026: AI Moves Supply Chains From Planning Toward Execution, But Data and Capacity Set the Pace
Tags: cold chain, vaccines, logistics, pharma, mRNA, storage